Correlation between monocyte count and progression of atherosclerosis in type2 diabetes

Not Applicable

• Conditions: type2 diabetic patients

• Registration Number: JPRN-UMIN000003526
• Lead Sponsor: Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-04-23
• Study Completion: 2013-12-18
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 360

Inclusion Criteria

Not provided

Exclusion Criteria

1.patients with infectious disease 2.patients with liver disfunction 3.patients with blood disease 4.Pregnant woman 5.other patients who are judged as unsuitable by investigators

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1: correlation between monocyte count and IMT. 2: correlation between monocyte count and PWV.

Secondary Outcome Measures

Name	Time	Method
1: correlation between leukocyte count and several factors as follow:TC, LDL, HDL-C, TG, HbA1c, HOMA-IR, TNFalpha, IL-6, adiponectin, solble insulin receptor. 2: correlation between leukocyte count and IMT. 3: correlation between leukocyte count and PWV. 4: correlation between leukocyte count and several factors as follow:TC, LDL, HDL-C, TG, HbA1c, HOMA-IR, TNFalpha, IL-6, adiponectin, solble insulin receptor.